Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment
Abstract Background Angioimmunoblastic T-cell lymphoma (AITL) is a malignancy with very poor survival outcome, in urgent need of more specific therapeutic strategies. The drivers of malignancy in this disease are CD4+ follicular helper T cells (Tfh). The metabolism of these malignant Tfh cells was n...
Shranjeno v:
| Principais autores: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2024-02-01
|
| Serija: | Journal of Experimental & Clinical Cancer Research |
| Teme: | |
| Online dostop: | https://doi.org/10.1186/s13046-024-02952-w |
| Oznake: |
Brez oznak, prvi označite!
|
